Interestingly, a recent in-depth meta-analysis of 1302 COVID-19 cases showed that the level of IL-6 was 3-fold higher in patients with severe vs mild/moderate COVID-19 (p < 0.001). The gene discussed is IL6; the disease is COVID-19.